Cargando…
Structural variation in the glycogen synthase kinase 3β and brain‐derived neurotrophic factor genes in Japanese patients with bipolar disorders
BACKGROUND: Lithium is the first‐line drug for the treatment of bipolar disorders (BDs); however, not all patients responded. Glycogen synthase kinase (GSK) 3β and brain‐derived neurotrophic factor (BDNF) play a role in the therapeutic action of lithium. Since structural variations were reported in...
Autores principales: | Suga, Yosuke, Yoshimoto, Keiichiro, Numata, Shusuke, Shimodera, Shinji, Takamura, Shogo, Kamimura, Naoto, Sawada, Ken, Kazui, Hiromitsu, Ohmori, Tetsuro, Morinobu, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292225/ https://www.ncbi.nlm.nih.gov/pubmed/31769621 http://dx.doi.org/10.1002/npr2.12083 |
Ejemplares similares
-
Plasma total homocysteine is associated with DNA methylation in patients with schizophrenia
por: Kinoshita, Makoto, et al.
Publicado: (2013) -
Decelerated epigenetic aging associated with mood stabilizers in the blood of patients with bipolar disorder
por: Okazaki, Satoshi, et al.
Publicado: (2020) -
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018) -
Meta-analyses of Blood Homocysteine Levels for Gender and Genetic Association Studies of the MTHFR C677T Polymorphism in Schizophrenia
por: Nishi, Akira, et al.
Publicado: (2014) -
PT614. Altered Serotonin transporter mRNA expression in the peripheral leukocytes of obsessive-compulsive disorder
por: Umehara, Hidehiro, et al.
Publicado: (2016)